 Home > Biochemistry News > Biotechnology News > Preliminary clinical trial results of innovative gene therapy to treat fatal childhood immunodeficiency are positive

Preliminary clinical trial results of innovative gene therapy to treat fatal childhood immunodeficiency are positive

 Last Update: 2021-11-01
 Source: Internet
 Author: User

Tags

oligopotent stem cells

cell markers

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, Rocket Pharmaceuticals announced that its research gene therapy RP-L201 has obtained positive interim data in a phase 1/2 clinical trial for the treatment of leukocyte adhesion deficiency type I (LAD-I)

The clinical manifestations of type I leukocyte adhesion deficiency are delayed umbilical cord shedding, repeated soft tissue infections and chronic periodontitis

RP-L201 is an in vitro autologous hematopoietic stem cell gene therapy based on lentiviral vector

This interim data comes from 7 patients with severe LAD-I, whose CD18 expression is less than 2%

Reference materials:

[1] Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT).

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.